Surgery Partners, Inc. SGRY 深 沪
等待开盘 03-26 09:30:00 美东时间
12.05
+0.050
+0.42%
华盛通- 最 高12.17
- 今 开12.11
- 成交量 94.42万股
- 最 低 11.665
- 昨 收 12.00
- 总市值 15.60亿
- 52周最高 24.18
- 市盈率 静 --
- 换手率 0.73%
- 52周最低 11.61
- 委 比 -5.44%
- 总股本 1.29亿
- 历史最高 69.58
- 量 比 0.61
- 振 幅 4.21%
- 历史最低 4.00
- 每 手 1
- 风险率 3.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Surgery Partners, Inc. to Present at Upcoming Investor Conference
Surgery Partners, Inc. (NASDAQ:SGRY) will present at the Barclays 28th Annual Global Healthcare Conference on March 10, 2026, at 2:30 p.m. ET. Investors can access a live webcast or replay via the company's investor relations website at www.surgerypartners.com. Founded in 2004, Surgery Partners is a leading healthcare services company with over 200 locations in 30 states, offering outpatient surgical and ancillary care.
03-09 16:04
美股大行评级 | 最高582美元！博通获多家机构上调目标价；GENI、Okta、Rigetti Computing、Veeva Systems、Wix.com遭多家机构下调目标价
今日重点评级关注：韦德布什：维持TScan Therapeutics"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持莱斯康制药"买入"评级，目标价从4美元升至6美元
03-06 11:58
Analyst Expectations For Surgery Partners's Future
Providing a diverse range of perspectives from bullish to bearish, 5 analysts h...
03-06 02:01
期权扫描 | Palantir连涨6日！一末日Call单暴涨逾130%；Coinbase飙涨14%后遭Put异动大单看空
特朗普警告要打“持久战”！Palantir连涨6日，一末日Call单暴涨逾130%；币圈立法助推Coinbase飙涨14%后，一Put异动大单逆势押注短线回调>>
03-05 17:26
美股大行评级 | 7家上调，3家下调！CrowdStrike绩后大行评级现分歧；罗斯百货、塔吉特、Viking获多家大行上调目标价
今日重点评级关注：古根海姆：维持Dianthus Therapeutics"买入"评级，目标价从100美元升至200美元；HC Wainwright & Co.：维持Amylyx Pharmaceuticals"买入"评级，目标价从28美元升至34美元
03-05 13:56
ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS
CHICAGO, March 4, 2026 /PRNewswire/ -- Ziegler, a specialty investment bank, is pleased to announce that it served as the exclusive financial advisor to Preferred Vascular Group (PVG) in con...
03-05 05:00
美股大行评级 | 绩后暴跌超22%，MongoDB遭14家大行集团下调目标价；挪威邮轮、阿莎娜、Quantum Computing等也遭大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NRX Pharmaceuticals"买入"评级，目标价从40美元升至45美元；RBC Capital：维持NUVATION BIO"跑赢大市"评级，目标价从12美元升至13美元
03-04 10:22
Barclays Maintains Equal-Weight on Surgery Partners, Lowers Price Target to $14
Barclays analyst Andrew Mok maintains Surgery Partners (NASDAQ:SGRY) with a Equal-Weight and lowers the price target from $18 to $14.
03-04 00:05
Surgery Partners Stock Hits 52-Week Low - Here's Why
Surgery Partners (NASDAQ: SGRY) shares drop in premarket as company reports lower than expected earnings and sets cautious 2026 outlook.
03-03 19:53
Why Ouster Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Shares of Ouster Inc (NASDAQ:OUST) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quar
03-03 18:27
